Venus Concept develops medical aesthetic device platforms and hair restoration technologies, including Venus Versa and ARTAS iX. The company operates in over 60 countries and targets demand for non‑invasive and minimally invasive procedures. Management is focused on optimizing the capital structure and streamlining operations to pursue sustained profitability. On September 26, 2024 Venus Concept exchanged $15 million of senior debt for equity as part of that effort. The company issued 203,583 shares of Series Y preferred stock in the transaction. Total debt obligations were reduced to approximately $34.6 million, down from $46 million three months earlier and $74.9 million at the end of 2023. Venus Concept has raised $115.72 million to date, was founded in 2009, and is based in Weston, Florida. Venus Concept Inc. announced receipt of $16.998967 million in funding from Masters Special Situations, LLC, Essex Woodlands Management, Inc., HealthQuest Capital, Masters Capital Management, L.L.C. and other investors. Concurrent with the financing, the company entered into a stock purchase agreement for a non‑brokered private placement. The private placement covers 9,808,418 common shares of par value $0.0001 and 3,790,755 preferred non‑voting shares. The transaction therefore involves issuance of both common and preferred equity securities. The announcement and disclosure focus on the financing and share issuance rather than operational or product details. Venus Concept develops, commercializes, and delivers aesthetic technologies and related practice enhancement services using a subscription-based business model. The company’s devices are designed to expand beyond traditional dermatology and plastic surgery markets into non-traditional settings such as family practice, general practice, internal medicine, obstetrics and gynecology, and medical spas. Venus Concept sells its devices in over 60 countries and operates 27 direct global offices. The company has expanded its subscription platform and employs over 400 global employees. Led by Chairman and CEO Domenic Serafino, Venus Concept plans ongoing product development to serve the aesthetic marketplace. The company intends to use recent funding to grow its subscription business and to expand and mature its direct office footprint. Venus Concept develops and distributes technology devices for skin tightening, body contouring and skin rejuvenation for the face, neck and body. Led by CEO Domenic Serafino, the company markets devices intended for pain-free aesthetic treatments. It operates through 14 offices worldwide. The company received a $20M senior secured term loan to support the ongoing commercialization of its device line. The financing was provided to back sales and commercialization efforts for its portfolio of aesthetic devices. Venus Concept is a leader in the global aesthetics market offering differentiated, comprehensive aesthetic solutions delivered through a partnership model with physicians. The company emphasizes best-in-class patient outcomes and dedicated customer service. Recent shareholder activity brought significant U.S. investor backing and was described by management as transformative. Management changes include Domenic Serafino assuming the role of Chairman and additions of senior regulatory and medical affairs leaders. Co-founder Oded Ron Edoute stepped down as Chairman but will continue working on development of the Chinese and Hong Kong markets. The company is positioning its leadership and investor base to support continued growth in target markets.

Total raised

$100M

Funding rounds

6

Latest round

Debt Financing

Latest activity

Sep 2024